Risk for Anaphylactic Reaction from Cardiac Catheterization in Patients receiving β-Adrenergic Blockers or Angiotensin converting enzyme-inhibitors.

ConclusionIn this case control-study, severe AR were rarely observed. Exposure to BB or ACE-I did not significantly influence AR frequency or severity; however, most BB were cardioselective. Our findings imply cardioselective BB or ACE-I suspension is not warranted in association with CC.
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research